Monday 30th June 2025

(1 day, 15 hours ago)

Commons Chamber
Read Full debate Read Hansard Text Watch Debate Read Debate Ministerial Extracts
Liz Kendall Portrait Liz Kendall
- View Speech - Hansard - - - Excerpts

I agree with my hon. Friend’s comments about the state of the economy. As I said in my statement, the four-point minimum will now not relate to existing claimants. It will come in for new claims in November 2026, but the Timms review and the co-production will look not only at the activities and the descriptors, but the points given to them. It is important that we do not set up a process of co-production and then overrule that. We want a benefits system that enables disabled people to have dignity and independence, and the same choices and chances to live the life that they want as anybody else has. It is a really important process, and I hope that she and many other hon. Members in the House will work with us to get this right.

Calum Miller Portrait Calum Miller (Bicester and Woodstock) (LD)
- View Speech - Hansard - -

I recently met a support group in my constituency of those who suffer from ME, chronic fatigue syndrome or long covid. Their description of the devastating impact of those variable conditions was very affecting. If one of those people were to have an improvement in their condition, meaning that they were no longer eligible for PIP, and then to represent for assessment, would they be entitled to return to the PIP level they were on previously, or would they be treated as new applicants under the terms the Secretary of State has described today?

Liz Kendall Portrait Liz Kendall
- View Speech - Hansard - - - Excerpts

The hon. Gentleman raises an important point, which is precisely what we want to look at in the PIP review, because it does not take into account fluctuating conditions. That is an important issue moving forward, and we will be absolutely determined to involve him, his constituents, and organisations that represent those with fluctuating conditions in the process of the review.